You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Treatment for lupus nephritis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2012
|
| DOI | 10.1002/14651858.cd002922.pub3 |
| Pubmed ID | |
| Authors |
Lorna Henderson, Philip Masson, Jonathan C Craig, Robert S Flanc, Matthew A Roberts, Giovanni FM Strippoli, Angela C Webster |
| Abstract |
Cyclophosphamide, in combination with corticosteroids has been used to induce remission in proliferative lupus nephritis, the most common kidney manifestation of the multisystem disease, systemic lupus erythematosus. Cyclophosphamide therapy has reduced mortality from over 70% in the 1950s and 1960s to less than 10% in recent years. Cyclophosphamide combined with corticosteroids preserves kidney function but is only partially effective and may cause ovarian failure, infection and bladder toxicity. Several new agents, including mycophenolate mofetil (MMF), suggest reduced toxicity with equivalent rates of remission. This is an update of a Cochrane review first published in 2004. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 20% |
| Australia | 1 | 20% |
| Brazil | 1 | 20% |
| Mexico | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 170 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Colombia | 1 | <1% |
| Uruguay | 1 | <1% |
| Italy | 1 | <1% |
| Unknown | 166 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 31 | 18% |
| Student > Master | 20 | 12% |
| Student > Postgraduate | 19 | 11% |
| Student > Ph. D. Student | 16 | 9% |
| Student > Bachelor | 15 | 9% |
| Other | 46 | 27% |
| Unknown | 23 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 98 | 58% |
| Nursing and Health Professions | 10 | 6% |
| Psychology | 6 | 4% |
| Agricultural and Biological Sciences | 5 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Other | 15 | 9% |
| Unknown | 32 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2023.
All research outputs
#1,968,805
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#4,177
of 13,140 outputs
Outputs of similar age
#17,185
of 288,465 outputs
Outputs of similar age from Cochrane database of systematic reviews
#57
of 195 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,465 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.